0001628280-23-018556.txt : 20230517 0001628280-23-018556.hdr.sgml : 20230517 20230517074323 ACCESSION NUMBER: 0001628280-23-018556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEIL GARRY ARTHUR CENTRAL INDEX KEY: 0001586785 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 23929648 MAIL ADDRESS: STREET 1: 555 CALIFORNIA STREET STREET 2: SUITE 365 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 wk-form4_1684323794.xml FORM 4 X0407 4 2023-05-15 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001586785 NEIL GARRY ARTHUR C/O AVALO THERAPEUTICS 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 1 0 0 CEO and Chairman of the Board 0 Stock Option (Right to Buy) 2.75 2023-05-15 4 A 0 100000 0 A 2024-05-15 2033-05-15 Common Stock 100000 100000 D The stock option will vest in full on May 15, 2024, subject to the Reporting Person's continued service on such vesting date. /s/ Jennifer Zoltoski, by Power of Attorney 2023-05-16